Le Lézard
Classified in: Health
Subject: HEALTH

Marijuana Victims' Association: Is Marijuana the New Thalidomide


VANCOUVER, BRITISH COLUMBIA--(Marketwired - Aug. 4, 2016) - Phocomelia (limb malformation) has been shown in testing(i) of THC marijuana in a similar preclinical model to that which revealed the teratogenicity of thalidomide.

The federal government is aware of serious marijuana harms; it must not be complicit in risking Canadian health, but must mitigate by placing marijuana products under a protective protocol similar to REVAID used for Thalidomide.

As the stewards of the country's human and financial resources, it is critical that government protect the public from potential irreversible harm and itself from litigation. Marijuana harm is not only possible but probable.

A Health Canada document cites 1,000 scientific references that substantiate the risks.

The June 2016 Government public consultation discussion paper fails to inform the public of the risks, specifically to the fetus and reproduction by males.

If thalidomide offered the "high" of pot would it be reasonable to legalizing it for recreational use?

(i)Ref: Reece AS, Hulse GK. Chromothripsis and epigenomics complete causality criteria for cannabis- and addiction-connected carcinogenicity, congenital toxicity and heritable genotoxicity. Mutat Res. 2016;789:15-25.

Contact Information:
Marijuana Victims' Association
Pamela McColl
SAM Canada
1-778 354 3551

These press releases may also interest you

at 06:11
XRP Healthcare Magazine proudly announces the release of its highly anticipated 2nd issue, delving into extraordinary philanthropical and benevolent programs on a global scale. This issue explores remarkable charity efforts in Africa and presents...

at 06:11
The Advanced Research Projects Agency for Health (ARPA-H) has announced a new funding opportunity through its Mission Office-specific Innovative Solution Openings (ISO). The funding opportunity aims to accelerate innovation and breakthroughs in...

at 06:05
Today, Portal Biotechnologies, Inc. ("Portal"), a cell engineering platform company, announced a $5M pre-seed round led by Pear VC, with participation from Conscience VC and 10x Capital. Portal is implementing a simplified approach to intracellular...

at 06:05
Fennec Pharmaceuticals Inc. , a commercial stage specialty pharmaceutical company, today announced that the Company will release its full year and fourth quarter 2023 financial results before the opening of the U.S. financial markets on Thursday,...

at 06:01
Continuing its commitment to financial inclusion in Indonesia, JULO has launched a distinctive nationwide healthcare financing feature. JULO Health is now available to finance Indonesians' healthcare needs across any of the nation's health facilities...

at 06:00
Pediatric Associates (PA) and Ambience Healthcare announced a partnership today, leveraging Ambience's AI operating system to enhance quality of care for patients, reduce documentation time for clinicians, and streamline pediatric workflows with a...



News published on and distributed by: